Aging health最新文献

筛选
英文 中文
Infections in older people 老年人感染
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.711
M. Vandewoude
{"title":"Infections in older people","authors":"M. Vandewoude","doi":"10.2217/1745509X.3.6.711","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.711","url":null,"abstract":"","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"711-714"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.711","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of photoselective vaporization of the prostate 前列腺光选择性汽化的评价
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.723
S. Gravas, M. Melekos, M. P. Laguna, J. Rosette
{"title":"Evaluation of photoselective vaporization of the prostate","authors":"S. Gravas, M. Melekos, M. P. Laguna, J. Rosette","doi":"10.2217/1745509X.3.6.723","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.723","url":null,"abstract":"Photoselective vaporization of the prostate is gaining wide acceptance in the urologic community. Published studies have provided data on the efficacy and safety of the photoselective vaporization of the prostate laser procedure, which seems to have an expanding role in the management of special benign prostatic hyperplasia populations, including patients with large prostates, patients under anticoagulation treatment and high-risk patients with comorbidities. This paper presents the current status of the clinical outcomes of photoselective vaporization of the prostate in the treatment of lower urinary tract symptoms due to benign prostatic obstruction. Cost of the method, speed of tissue removal, need for larger high-quality studies with long-term follow-up and the introduction of the new 120-W high-performance system vaporization are also discussed this review.","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"723-730"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.723","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prioritizing care for older adults with multiple comorbidities: working in the ‘zone of complexity’ 优先照顾有多种合并症的老年人:在“复杂地带”工作
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.715
S. Durso
{"title":"Prioritizing care for older adults with multiple comorbidities: working in the ‘zone of complexity’","authors":"S. Durso","doi":"10.2217/1745509X.3.6.715","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.715","url":null,"abstract":"Prioritizing care for older adults with multiple comorbid conditions is a challenging act of clinical judgment owing to the multidimensional and dynamic nature of each patient’s health status. This clinical process is analogous to working within a complex adaptive system, where an intervention or change in one condition can produce unexpected outcomes. Except for decisions characterized by a high degree of professional agreement (e.g., influenza vaccination), most medical decisions affecting older adults occur within a ‘zone of complexity’ characterized by imperfect agreement regarding best practices and outcomes. An example is setting individual glycemic targets. Decisions within this zone are at best bounded by a few principles: first, ascertain the patient’s preferences and goals; second, determine health status by identifying relevant comorbid conditions, function and frailty; third, consider the risks and benefits, and estimate the likelihood that any intervention will achieve the patient’s healthcar...","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"715-721"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.715","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy and safety of ezetimibe and ezetimibe plus statin therapy in patients aged under 65, 65–74 and 75 years and older 依折麦布和依折麦布联合他汀类药物治疗65岁以下、65 - 74岁和75岁及以上患者的疗效和安全性
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.691
Jennifer G. Robinson, M. Davidson, Arvind K. Shah, Jianxin Lin, D. Neff, P. Delucca, J. Tomassini, E. Veltri, A. Tershakovec
{"title":"Efficacy and safety of ezetimibe and ezetimibe plus statin therapy in patients aged under 65, 65–74 and 75 years and older","authors":"Jennifer G. Robinson, M. Davidson, Arvind K. Shah, Jianxin Lin, D. Neff, P. Delucca, J. Tomassini, E. Veltri, A. Tershakovec","doi":"10.2217/1745509X.3.6.691","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.691","url":null,"abstract":"Although the greatest burden of cardiovascular disease occurs after age 65 years, limited efficacy and safety data are available for cholesterol-lowering drugs in elderly patients. We undertook a pooled analysis of individual data from 13,282 patients aged 18–93 years in 16 published trials of ezetimibe and ezetimibe added on to or coadministered with a statin (ezetimibe/statin). Overall, ezetimibe reduced low-density lipoprotein cholesterol by 20% compared with placebo and ezetimibe/statin reduced low-density lipoprotein cholesterol by 17% compared with a statin alone, with consistent treatment effects across age groups (<65, 65–74 and ≥75 years). Rates of any adverse or drug-related adverse events were also similar across age groups. We conclude that the lipid efficacy and safety of ezetimibe and ezetimibe/statin in those aged 65–74 and 75 years and older are similar to those observed in patients aged under 65 years.","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"691-705"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.691","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Current perspectives: fecal incontinence in older adults 当前观点:老年人大便失禁
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.751
C. M. Schüssler-Fiorenza, A. Wald
{"title":"Current perspectives: fecal incontinence in older adults","authors":"C. M. Schüssler-Fiorenza, A. Wald","doi":"10.2217/1745509X.3.6.751","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.751","url":null,"abstract":"Fecal incontinence is an important health issue that has devastating psychological, social and economic consequences for the aging population. However, it is under-reported and under-treated, often because of mistaken assumptions that incontinence is a normal part of aging and that little can be done about it. There are effective treatments that can be easily implemented in the primary-care setting, which can greatly improve an older person’s quality of life and potentially avert premature referral to a nursing home. Therefore, it is important that clinicians screen for the problem and are comfortable with its evaluation and treatment. This article reviews the epidemiology of fecal incontinence, approaches to improving identification and quality of care, as well as the assessment and treatment of the most common etiologies of fecal incontinence.","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"751-765"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.751","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Current understanding of the concept of frailty in later life 目前对晚年虚弱概念的理解
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.767
D. Hogan
{"title":"Current understanding of the concept of frailty in later life","authors":"D. Hogan","doi":"10.2217/1745509X.3.6.767","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.767","url":null,"abstract":"Frailty has attracted increasing attention in the medical literature over the last 20 years. What is it? Why is it important? How does it arise? Can it be recognized? What is recommended for its management? In this review we try to address all these questions and also assess what has to be done to further our understanding of frailty and its management.","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"767-776"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.767","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Post-traumatic stress disorder in older people 老年人的创伤后应激障碍
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.743
M. Chung
{"title":"Post-traumatic stress disorder in older people","authors":"M. Chung","doi":"10.2217/1745509X.3.6.743","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.743","url":null,"abstract":"Research into post-traumatic stress disorder (PTSD) among older people is in its ascendancy. Several reviews have been published to capture the main arguments of the studies from 1994 to 2000. This article aims to review published studies from 2000 onwards on PTSD among older people. These studies show that following their exposure to different types of traumas, older people have been shown to develop PTSD symptoms, a range of psychiatric comorbidity and cognitive and biological changes. On the whole, PTSD reactions do not vary across age groups, although this finding is not entirely conclusive. There seems to be evidence demonstrating ethnic differences in terms of PTSD reactions. Despite some anecdotal evidence, research has not focused on evaluating therapeutic interventions for older people with PTSD.","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"743-749"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.743","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Canadian Coalition for Seniors’ Mental Health 2nd National Conference 加拿大老年人心理健康联盟第二届全国会议
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.707
Faith Malach, K. Wilson
{"title":"Canadian Coalition for Seniors’ Mental Health 2nd National Conference","authors":"Faith Malach, K. Wilson","doi":"10.2217/1745509X.3.6.707","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.707","url":null,"abstract":"","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"707-710"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.707","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
of osteonecrosis of the jaw on osteoporosis management: executive summary of an ESCEO and Foundation for Research on Osteoporosis and other Bone Diseases Working Group Meeting 颌骨骨坏死对骨质疏松管理的影响:ESCEO和骨质疏松及其他骨病研究基金会工作组会议的执行摘要
Aging health Pub Date : 2007-12-12 DOI: 10.2217/1745509X.3.6.731
R. Rizzoli, N. Burlet, D. Cahall, P. Delmas, E. Eriksen, D. Felsenberg, J. Grbic, M. Jontell, R. Landesberg, A. Laslop, P. Matton, S. Papapoulos, O. Sezer, M. Sprafka, J. Reginster
{"title":"of osteonecrosis of the jaw on osteoporosis management: executive summary of an ESCEO and Foundation for Research on Osteoporosis and other Bone Diseases Working Group Meeting","authors":"R. Rizzoli, N. Burlet, D. Cahall, P. Delmas, E. Eriksen, D. Felsenberg, J. Grbic, M. Jontell, R. Landesberg, A. Laslop, P. Matton, S. Papapoulos, O. Sezer, M. Sprafka, J. Reginster","doi":"10.2217/1745509X.3.6.731","DOIUrl":"https://doi.org/10.2217/1745509X.3.6.731","url":null,"abstract":"The first reports of osteonecrosis of the jaw in patients taking bisphosphonates to reduce excessive bone resorption were published in 2003. Subsequent reports raised concern and resulted in manufacturers writing letters of caution to physicians and dentists. Recommendations were issued by the US FDA, and the European Agency for the Evaluation of Medicinal Products requested that pharmaceutical companies update their product information and package leaflets. The European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis and the Foundation for Research on Osteoporosis and other Bone Diseases Working Group Meeting was convened on 14 December 2006 in Geneva, Switzerland, to review the available data and published guidelines on this rare but serious condition. The purpose of the meeting was to assess the impact of osteonecrosis of the jaw on the management of osteoporosis. The discussion focused on the current definition of osteonecrosis of the jaw, its epidemiology and pathophysiolo...","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"731-734"},"PeriodicalIF":0.0,"publicationDate":"2007-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.6.731","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Brachytherapy monotherapy for older men with prostate cancer 老年前列腺癌患者的近距离单药治疗
Aging health Pub Date : 2007-10-30 DOI: 10.2217/1745509X.3.5.653
J. Tward, D. Shrieve
{"title":"Brachytherapy monotherapy for older men with prostate cancer","authors":"J. Tward, D. Shrieve","doi":"10.2217/1745509X.3.5.653","DOIUrl":"https://doi.org/10.2217/1745509X.3.5.653","url":null,"abstract":"Men with low-risk localized prostate cancer are presented with several definitive treatment choices: radical prostatectomy, external-beam radiotherapy or brachytherapy. Although these three treatment choices confer a statistically equivalent likelihood of long- term disease-free survival, these therapies differ in their acute and long-term side-effect profiles. Brachytherapy is a minimally invasive radiotherapy procedure, and is an excellent treatment in men who do not want, or are unable to tolerate, a prostatectomy. The following article will present an overview of the epidemiology of prostate cancer, brachytherapy eligibility and a description of the techniques, side effects and efficacy, with a special emphasis on applicability to older men.","PeriodicalId":88353,"journal":{"name":"Aging health","volume":"3 1","pages":"653-661"},"PeriodicalIF":0.0,"publicationDate":"2007-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/1745509X.3.5.653","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68187455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书